Cargando…

The Role of Neutrophils in Oncolytic Orf Virus-Mediated Cancer Immunotherapy

Neutrophils are innate leukocytes with diverse effector functions that allow them to respond to pathogens rapidly. Accumulating evidence has highlighted these cells’ complex roles in the host’s response to viral infections and tumor progression. Oncolytic virotherapy is emerging as a promising treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minott, Jessica A., van Vloten, Jacob P., Chan, Lily, Mehrani, Yeganeh, Bridle, Byram W., Karimi, Khalil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496759/ https://www.ncbi.nlm.nih.gov/pubmed/36139433 http://dx.doi.org/10.3390/cells11182858

Ejemplares similares

The Potential of Dendritic-Cell-Based Vaccines to Modulate Type 3 Innate Lymphoid Cell Populations
por: Chan, Lily, et al.
Publicado: (2023)

Dendritic Cell Vaccines Impact the Type 2 Innate Lymphoid Cell Population and Their Cytokine Generation in Mice
por: Chan, Lily, et al.
Publicado: (2023)

Characterization of the Impact of Oncolytic Vesicular Stomatitis Virus on the Trafficking, Phenotype, and Antigen Presentation Potential of Neutrophils and Their Ability to Acquire a Non-Structural Viral Protein
por: Stegelmeier, Ashley A., et al.
Publicado: (2020)

The Roles of Neutrophils in Cytokine Storms
por: Chan, Lily, et al.
Publicado: (2021)

Dendritic Cell-Based Vaccines Recruit Neutrophils to the Local Draining Lymph Nodes to Prime Natural Killer Cell Responses
por: Chan, Lily, et al.
Publicado: (2022)

Multiplex flow cytometry-based assay for quantifying tumor- and virus-associated antibodies induced by immunotherapies
por: Minott, Jessica A., et al.
Publicado: (2022)

Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer
por: van Vloten, Jacob P, et al.
Publicado: (2022)

Type I Interferon α/β Receptor-Mediated Signaling Negatively Regulates Antiviral Cytokine Responses in Murine Bone-Marrow-Derived Mast Cells and Protects the Cells from Virus-Induced Cell Death
por: Darzianiazizi, Maedeh, et al.
Publicado: (2020)

Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells
por: Hafezi, Bahareh, et al.
Publicado: (2021)

Review of Influenza Virus Vaccines: The Qualitative Nature of Immune Responses to Infection and Vaccination Is a Critical Consideration
por: Chan, Lily, et al.
Publicado: (2021)

Production and purification of high-titer OrfV for preclinical studies in vaccinology and cancer therapy
por: van Vloten, Jacob P., et al.
Publicado: (2021)

Neutrophils in Dendritic Cell-Based Cancer Vaccination: The Potential Roles of Neutrophil Extracellular Trap Formation
por: Chan, Lily, et al.
Publicado: (2023)

Myeloid Cells during Viral Infections and Inflammation
por: Stegelmeier, Ashley A., et al.
Publicado: (2019)

Mechanisms that allow vaccination against an oncolytic vesicular stomatitis virus-encoded transgene to enhance safety without abrogating oncolysis
por: AuYeung, Amanda W. K., et al.
Publicado: (2021)

Quantifying Antibody Responses Induced by Antigen-Agnostic Immunotherapies
por: van Vloten, Jacob P., et al.
Publicado: (2019)

Murine Mast Cells That Are Deficient in IFNAR-Signaling Respond to Viral Infection by Producing a Large Amount of Inflammatory Cytokines, a Low Level of Reactive Oxygen Species, and a High Rate of Cell Death
por: Mehrani, Yeganeh, et al.
Publicado: (2023)

Neutrophil Functional Heterogeneity and Implications for Viral Infections and Treatments
por: Chan, Lily, et al.
Publicado: (2022)

Quantifying Antigen-Specific T Cell Responses When Using Antigen-Agnostic Immunotherapies
por: van Vloten, Jacob P., et al.
Publicado: (2019)

Use of Precision-Cut Lung Slices as an Ex Vivo Tool for Evaluating Viruses and Viral Vectors for Gene and Oncolytic Therapy
por: Rosales Gerpe, María C., et al.
Publicado: (2018)

Vitamin D Influences the Activity of Mast Cells in Allergic Manifestations and Potentiates Their Effector Functions against Pathogens
por: Mehrani, Yeganeh, et al.
Publicado: (2023)

Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils
por: Stegelmeier, Ashley A., et al.
Publicado: (2021)

Oncolytic Virus Immunotherapy
por: Marchini, Antonio, et al.
Publicado: (2021)

Tumor Temperature: Friend or Foe of Virus-Based Cancer Immunotherapy
por: Knapp, Jason P., et al.
Publicado: (2022)

Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models
por: McAusland, Thomas M., et al.
Publicado: (2021)

Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8(+) T-cell responses to anticancer vaccines
por: Bridle, Byram W, et al.
Publicado: (2013)

Development and applications of oncolytic Maraba virus vaccines
por: Pol, Jonathan G, et al.
Publicado: (2018)

Fusogenic Viruses in Oncolytic Immunotherapy
por: Krabbe, Teresa, et al.
Publicado: (2018)

Oncolytic viruses for cancer immunotherapy
por: Hemminki, Otto, et al.
Publicado: (2020)

Measles Virus as an Oncolytic Immunotherapy
por: Engeland, Christine E., et al.
Publicado: (2021)

Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning
por: Pol, Jonathan G, et al.
Publicado: (2020)

Enhancing Immune Responses to Cancer Vaccines Using Multi-Site Injections
por: Mould, Robert C., et al.
Publicado: (2017)

Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
por: Guo, Zong Sheng, et al.
Publicado: (2019)

Oncolytic herpes simplex virus and immunotherapy
por: Ma, Wenqing, et al.
Publicado: (2018)

Perspectives on immunotherapy via oncolytic viruses
por: Reale, Alberto, et al.
Publicado: (2019)

Ferroptosis Inducer Improves the Efficacy of Oncolytic Virus-Mediated Cancer Immunotherapy
por: Liu, Weilin, et al.
Publicado: (2022)

Targeting Autophagy for Oncolytic Immunotherapy
por: Hu, Lulu, et al.
Publicado: (2017)

Oncolytic viruses as immunotherapy: progress and remaining challenges
por: Aurelian, Laure
Publicado: (2016)

Oncolytic virus immunotherapy: future prospects for oncology
por: Raja, Junaid, et al.
Publicado: (2018)

Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma
por: Yoo, So Young, et al.
Publicado: (2017)

Oncolytic Viruses: Priming Time for Cancer Immunotherapy
por: Russell, Luke, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8d6so8v15o59p27inf3h02u0bo